News
The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...
The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...
As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind ...
To learn more, a team of researchers retrospectively analyzed electronic health record data from 4,983 ED visits for SCD-related pain in children using the Pediatric Emergency Care Applied Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results